Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2000
02/17/2000WO2000008179A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases
02/17/2000WO2000008178A2 Murine dna molecules encoding polypeptides having kinase functions
02/17/2000WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000WO2000008176A1 Mutated barnase gene and plant transformed by the same
02/17/2000WO2000008175A2 Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
02/17/2000WO2000008173A1 Identification and functional characterization of a novel ribosomal s6 protein kinase
02/17/2000WO2000008172A1 Method to alter the fatty acid metabolism in plants
02/17/2000WO2000008171A1 N-acetylglycosaminyl transferase genes
02/17/2000WO2000008164A2 Thermostable in vitro complex with polymerase activity
02/17/2000WO2000008162A1 A Pi-ta GENE CONFERRING DISEASE RESISTANCE TO PLANTS
02/17/2000WO2000008161A1 Transgenic plants with the expression of soybean glycinin
02/17/2000WO2000008160A2 A plant disease resistance signalling gene: materials and methods relating thereto
02/17/2000WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000WO2000008149A2 Human neuronal acid-sensitive cationic channels, its cloning and applications
02/17/2000WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000WO2000008145A2 Novel genes in control of hematopoiesis
02/17/2000WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3
02/17/2000WO2000008142A2 Fibrous proteins and the production thereof
02/17/2000WO2000008139A1 Tumor necrosis factor-gamma
02/17/2000WO2000008137A2 Transgenic animals having a modified glycoprotein v gene
02/17/2000WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE
02/17/2000WO2000008132A1 Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof
02/17/2000WO2000008130A2 Method for preparing a cartilage cell suspension
02/17/2000WO2000008054A1 Modified green fluorescent protein
02/17/2000WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000WO2000008043A2 Prevention and treatment of viral disease
02/17/2000WO2000007619A1 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
02/17/2000WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
02/17/2000WO2000007617A1 Use of glp-1 and analogues for preventing type ii diabetes
02/17/2000WO2000007545A2 Apoptosis proteins
02/17/2000WO2000007432A1 Biodegradable high oxidative stability oils
02/17/2000WO2000007431A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof
02/17/2000WO2000007430A2 Plant fatty acid desaturase promoters
02/17/2000WO2000007427A2 Method for selective and optionally reversible degeneration of somatic plant tissue
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000WO1999064451A3 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof
02/17/2000WO1999063101A3 Transfected cells and methods for treating diabetes
02/17/2000WO1999058691A3 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
02/17/2000WO1999058675A3 Human genes and gene expression products v
02/17/2000WO1999057241A9 Myelin basic protein peptides and uses thereof
02/17/2000WO1999053036A9 Ste20-related protein kinases
02/17/2000WO1999051779A9 Glaucoma therapeutics and diagnostics
02/17/2000DE19912798C1 Culturing human cancer cells for molecular biology research comprises culturing fragments of tissue slices
02/17/2000DE19834909A1 Faserproteine und ihre Herstellung Fibrous proteins and their preparation
02/17/2000CA2672025A1 Genes involved in tolerance to environmental stress
02/17/2000CA2362013A1 Transgenic plant expressing soybean glycinin
02/17/2000CA2342078A1 New salicylic acid inducible genes and promoters from tobacco
02/17/2000CA2339891A1 Chp polypeptide, a ligand of pak65
02/17/2000CA2339734A1 Gel microdrops in genetic analysis
02/17/2000CA2339365A1 Biodegradable high oxidative stability oils
02/17/2000CA2339352A1 N-acetylglycosaminyltransferase genes
02/17/2000CA2339347A1 Novel g protein-coupled receptor cdna sequence
02/17/2000CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2339084A1 Plant fatty acid desaturase promoters
02/17/2000CA2338983A1 Prevention and treatment of viral disease
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2338383A1 Method for selective and optionally reversible degeneration of somatic plant tissue
02/17/2000CA2338187A1 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
02/17/2000CA2338185A1 Thermostable in vitro complex with polymerase activity
02/17/2000CA2338003A1 Nucleic acid module coding for alpha-glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
02/17/2000CA2338002A1 Plants synthesizing a modified starch, process for the generation of the plants, their use, and the modified starch
02/17/2000CA2337980A1 Method to alter the fatty acid metabolism in plants
02/17/2000CA2337904A1 Novel genes in control of hematopoiesis
02/17/2000CA2337861A1 A plant disease resistance signalling gene: materials and methods relating thereto
02/17/2000CA2337741A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000CA2337694A1 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof
02/17/2000CA2337693A1 Transgenic animals having a modified glycoprotein v gene
02/17/2000CA2336592A1 Cell lines for the propagation of mutated herpes viruses
02/17/2000CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000CA2336064A1 Fibrous proteins and the production thereof
02/17/2000CA2328494A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease
02/17/2000CA2305784A1 Mutated barnase gene and plant transformed by the same
02/17/2000CA2305680A1 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000CA2305308A1 Human cdnas encoding polypeptides having kinase functions
02/16/2000EP0979873A1 Gene for petunia transcription factor PetSPL2 and its use
02/16/2000EP0979870A1 Human Wnt-6 polypeptide
02/16/2000EP0979298A1 Metastasis models using green fluorescent protein (gfp) as a marker
02/16/2000EP0979297A1 A conditional replication and expression system
02/16/2000EP0979293A1 Transcriptional silencing elements and their binding factors
02/16/2000EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein
02/16/2000EP0979289A1 Human lysophospholipase
02/16/2000EP0979288A2 Diagnosis and treatment of phosphatase- or kinase-related disorders
02/16/2000EP0979282A1 Rat st38.2 chemokine
02/16/2000EP0979281A2 A method for making multispecific antibodies having heteromultimeric and common components
02/16/2000EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein
02/16/2000EP0979279A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
02/16/2000EP0979276A1 Complement receptor type 1 (cr1)-like sequences
02/16/2000EP0979274A2 Human p24 vesicle proteins
02/16/2000EP0979271A1 Vascular adhesion protein-1 having amine oxidase activity
02/16/2000EP0979235A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
02/16/2000EP0979102A1 Polyalkylene oxide-modified single chain polypeptides
02/16/2000EP0979031A1 Compositions and methods for plant transformation and regeneration
02/16/2000CN1244895A Carrot anti-freeze polypeptides
02/16/2000CN1244894A Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
02/16/2000CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use
02/16/2000CN1244803A Soluble CTLA4 mutant molecules and uses thereof
02/16/2000CN1244772A Targeted cytotoxic cell
02/16/2000CN1244585A Method for leading-in petunia transcription factor Pet SPL 2 gene to shorten inflorescence internode
02/16/2000CN1244582A Fast Diyongjinlian trollius propagating technology
1 ... 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 ... 1827